A major risk of breast cancer screening may have been overestimated for decades

AI Summary

A recent study reanalyzed major breast cancer screening trials and found that the overdiagnosis rate due to mammograms is below 5%, significantly lower than previous estimates of 30% to 50%. This new evaluation accounted for key variables like follow-up time and screening frequency to provide more accurate risk assessments.

A new analysis suggests mammograms may lead to far less breast cancer overdiagnosis than some earlier studies indicated. Researchers reexamined all eight major randomized screening trials and accounted for differences in follow-up time, screening frequency, and screening after trials ended. Their results were consistent with an overdiagnosis rate below 5%, rather than estimates approaching 30% to 50%.